Targeted alpha therapy of ovarian cancer with 212Pb-labeled anti-PTK7 antibody: On-site 212Pb production and preclinical insights
- DOI
- 10.1016/j.nucmedbio.2025.109570
- Published
- 2025-11
- Container
- Nuclear Medicine and Biology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.nucmedbio.2025.109570,
title = {Targeted alpha therapy of ovarian cancer with 212Pb-labeled anti-PTK7 antibody: On-site 212Pb production and preclinical insights},
author = {Yani Berckmans and Roxanne Wouters and Zeljka Raskovic-Lovre and Sara Van Mechelen and Kim Lindland and Tina Bønsdorff and An Coosemans and Frederik Cleeren},
year = {2025},
journal = {Nuclear Medicine and Biology},
doi = {10.1016/j.nucmedbio.2025.109570},
url = {https://doi.org/10.1016/j.nucmedbio.2025.109570}
}RIS
TY - JOUR TI - Targeted alpha therapy of ovarian cancer with 212Pb-labeled anti-PTK7 antibody: On-site 212Pb production and preclinical insights AU - Yani Berckmans AU - Roxanne Wouters AU - Zeljka Raskovic-Lovre AU - Sara Van Mechelen AU - Kim Lindland AU - Tina Bønsdorff AU - An Coosemans AU - Frederik Cleeren PY - 2025 JO - Nuclear Medicine and Biology DO - 10.1016/j.nucmedbio.2025.109570 UR - https://doi.org/10.1016/j.nucmedbio.2025.109570 ER -
APA
Berckmans, Y., Wouters, R., Raskovic-Lovre, Z., Mechelen, S. V., Lindland, K., Bønsdorff, T., Coosemans, A., & Cleeren, F. (2025). Targeted alpha therapy of ovarian cancer with 212Pb-labeled anti-PTK7 antibody: On-site 212Pb production and preclinical insights. Nuclear Medicine and Biology. https://doi.org/10.1016/j.nucmedbio.2025.109570
Source records
- crossref · retrieved 2026-09-26T13:00:35.412Z